Management of multiple myeloma during COVID-19 pandemic
At the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-01-01
|
| Series: | Leukemia Research Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048920300182 |
| id |
doaj-7ad770cfce514e84ba10cce7137f073c |
|---|---|
| record_format |
Article |
| spelling |
doaj-7ad770cfce514e84ba10cce7137f073c2020-12-19T05:05:47ZengElsevierLeukemia Research Reports2213-04892020-01-0114100212Management of multiple myeloma during COVID-19 pandemicYS Jethava0Rafael Fonseca1Ola Landgren2Division of Hematology and Cellular Therapy, University of Iowa Hospitals and Clinics, 200 Hawkins Dr, 5970 JPP, Iowa City, IA 52242, United States; Corresponding author.Interim Executive Director, Mayo Clinic Comprehensive Cancer Center, Director for Innovation and Transformational Relationships, Getz Family Professor of Cancer, Distinguished Mayo Investigator, 5777 East Mayo Boulevard, Phoenix, AZ 85054, United StatesMyeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United StatesAt the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began to characterize it as a pandemic. The virus that causes COVID-19 is designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019.http://www.sciencedirect.com/science/article/pii/S2213048920300182 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
YS Jethava Rafael Fonseca Ola Landgren |
| spellingShingle |
YS Jethava Rafael Fonseca Ola Landgren Management of multiple myeloma during COVID-19 pandemic Leukemia Research Reports |
| author_facet |
YS Jethava Rafael Fonseca Ola Landgren |
| author_sort |
YS Jethava |
| title |
Management of multiple myeloma during COVID-19 pandemic |
| title_short |
Management of multiple myeloma during COVID-19 pandemic |
| title_full |
Management of multiple myeloma during COVID-19 pandemic |
| title_fullStr |
Management of multiple myeloma during COVID-19 pandemic |
| title_full_unstemmed |
Management of multiple myeloma during COVID-19 pandemic |
| title_sort |
management of multiple myeloma during covid-19 pandemic |
| publisher |
Elsevier |
| series |
Leukemia Research Reports |
| issn |
2213-0489 |
| publishDate |
2020-01-01 |
| description |
At the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began to characterize it as a pandemic. The virus that causes COVID-19 is designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019. |
| url |
http://www.sciencedirect.com/science/article/pii/S2213048920300182 |
| work_keys_str_mv |
AT ysjethava managementofmultiplemyelomaduringcovid19pandemic AT rafaelfonseca managementofmultiplemyelomaduringcovid19pandemic AT olalandgren managementofmultiplemyelomaduringcovid19pandemic |
| _version_ |
1724377877243232256 |